LIPODYSTROPHY
Clinical trials for LIPODYSTROPHY explained in plain language.
Never miss a new study
Get alerted when new LIPODYSTROPHY trials appear
Sign up with your email to follow new studies for LIPODYSTROPHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for rare leptin disorders: expanded access to REGN4461
Disease control AVAILABLEThis program provides expanded access to REGN4461 for people with lipodystrophy or monogenic obesity caused by a lack of leptin signaling. The goal is to help manage these rare conditions by replacing the missing leptin signal. Participants must have a confirmed diagnosis and no …
Matched conditions: LIPODYSTROPHY
Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated May 26, 2026 03:06 UTC
-
Pregnancy mystery: does a Fat-Loss drug help or harm?
Knowledge-focused Recruiting nowThis study looks at women with lipodystrophy (a condition causing abnormal fat loss) who have been pregnant, both those who took the drug metreleptin and those who did not. Researchers will collect information on pregnancy complications and the health of the children. The goal is…
Matched conditions: LIPODYSTROPHY
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated May 26, 2026 03:10 UTC
-
Scientists dive deep into fat storage mystery
Knowledge-focused Recruiting nowThis study aims to understand how fat is stored in people with familial partial lipodystrophy (FPLD), a condition that leads to serious health issues like diabetes and heart disease. Researchers will compare fat tissue samples from 14 participants (some with FPLD, some healthy) a…
Matched conditions: LIPODYSTROPHY
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated May 13, 2026 15:58 UTC